Le Lézard
Classified in: Health
Subjects: EXE, POL, RCL, PSF

Information Update - Unauthorized weight loss product "AD Elite Series Shredabull Untamed," sold at Active Body Nutrition in Kelowna, B.C., may pose serious health risks



OTTAWA, Dec. 29, 2017 /CNW/ - Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.

 

Unauthorized health products

Product &

Promoted Use

Hazard Identified

Company

Action Taken

AD Elite Series Shredabull Untamed
Weight loss

Labelled to contain bovine thyroid and yohimbe

Active Body Nutrition

100-1634 Harvey Ave

Kelowna, B.C.

Removed from sale at retail location

 

Health Canada maintains a list of unauthorized health products that may pose serious health risks so that Canadians can easily identify those they may have purchased and take appropriate action. Canadians are encouraged to check back regularly for updates.

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 17:30
The "Technology Innovations Enabling Precision Robotic Surgery" report has been added to ResearchAndMarkets.com's offering. This research service offers a strategic perspective of the customer, product, technology and competitors that are...

at 17:28
Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Department of Health and Human Services' proposal requiring drug companies to disclose the list price of prescription drugs in...

at 17:25
CINCINNATI, Oct. 15, 2018 /PRNewswire-PRWeb/ -- The Victory of Light Psychic Festival, one of the nation's largest metaphysical conventions for the general public, has announced its lineup of more than 300 psychics, healers and exhibitors returning...

at 17:22
SpeakEasy Cannabis Club Ltd. (the "Company" or "SpeakEasy") a late stage applicant under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), is pleased to provide a Company update to shareholders. ABOUT SPEAKEASY Over the last few...

at 17:03
Emblem Corp. ("Emblem" or the "Company") today announced that it will segregate CDN $5 million of its current cash holdings to establish what it is calling the Patient Access Investment Fund (the "Fund"), the interest from which will be used to help...

at 17:01
Canopy Growth Corporation ("Canopy Growth" or the "Company") will release its financial results for the second quarter fiscal 2019 ended September 30, 2018 on November 14, 2018. Following the release of its second quarter 2019 financial results,...




News published on 29 december 2017 at 13:17 and distributed by: